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background:  Although it is required that patients be hospitalized for initiation of dofetilide, the safety of dofetilide reloading, justifying need 
for inpatient re-hospitalization, has not been investigated.
Methods:  We performed a retrospective medical record review of 1543 patients who were admitted for dofetilide loading for atrial 
arrhythmias from 2008 to 2012 at Cleveland Clinic. We compared the incidence of Torsade de pointes (TdP) for dofetilide reloading (139 
patients) to dofetilide initial loading (1404 patients) and evaluated the need for dose adjustment due to prolonged QT interval.
results:  TdP occurred in 2 of 139 patients (1.4%) who were admitted for dofetilide reloading, which was not statistically different from the 
rate of 1.2 % in 17/1404 patients who were admitted for dofetilide initial loading (p=0.82). In the reloading group, one patient had cardiac 
arrest requiring defibrillation and the other patient had TdP with associated shortness of breath when spontaneously converting to normal 
sinus. Both were admitted to increase their dose of dofetilide from the previously tolerated dose. For patients who were reloaded with their 
previous dose, no TdP occurred, but 29/102 patients (28.4%) required dose adjustment due to prolonged QT interval. 
Conclusion:  These results support readmission for dofetilide reloading, especially if dosage is to be increased. Requirement for downward 
dosage adjustments is common for patients readmitted for re-initiation of previously tolerated doses.
